Post

Dr. Gunnveig Grødeland, Research Group Lead, Influenza and Adaptive Immunity, Institute for Clinical Medicine, University of Oslo

Post

Dr. Holger Kissel Vice President Business Alliances at BioNTechabout NLSDays’ Vaccine Crosslinks: From Cancer to COVID super session

Post

Follow the money – Investors leading the way to sustainability

Post

Power up Through Partnerships!

Post

Per Falk from Ferring about NLSDays’ Gender Science super session

Post

Masha Strømme from PAACS about NLSDays’ Gender Science super session

Post

Christina Östberg Lloyd from Pharmiva about NLSDays’ Gender Science super session

Post

Writing a new Nordic Saga…

Post

Karin Conde-Knape about NLSDays’ super session : ‘From Population to Precision’

Post

NLSDays – NLSInvest: What are international investors are looking for?

Post

NLSInvest: What’s in it for Nordic Life Science companies?

Post

Abdel Halim about NLSDays’ super session : ‘From Population to Precision’

Post

Sam Oddson from SidekickHealth about NLSDays’ The new cross-industry playground super session

Post

Jessica Shull from Digital Therapeutics Alliance about NLSDays’ The new cross-industry playground super session

Post

NLSDays – NLSInvest: What are international investors are looking for?

Post

NLSDays – NLSInvest: What are international investors are looking for?

Post

NLSInvest: What’s in it for Nordic Life Science companies?

Post

NLSDays – NLSInvest: What are international investors are looking for?

Post

Sarah Lidé from Medicon Valley Alliance about NLSDays’ Microbiome super session

Post

NLSInvest: What’s in it for Nordic Life Science companies?

Post

NLSInvest – NLSDays: Why returning on a regular basis?

Post

Dr Gianfranco Grompone BioGaia CSO about NLSDays’ Microbiome super session

Post

Cytiva CEO Shares His Commitment to Nordic Life Sciences and Entrepreneurs